The VIX hit a 23-year low on Friday, as the major stock market indexes hit new highs
It was a quiet start to the week for the
stock market, with investors taking a wait-and-see approach ahead of a number of market-moving events. Growing tensions in the Middle East put pressure on
oil prices, while back at home traders kept a close eye on Apple's
Worldwide Developers Conference (WWDC). The
energy sector would stay in focus, too, after a surprising update on domestic
crude supplies -- good news for
United States Oil Fund (USO) options traders. But by Thursday, attention quickly shifted to the
European Central Bank's (ECB) policy decision, as well as the congressional testimony of former FBI Director
James Comey.
Stocks Hit Record Highs Despite U.K. Election Uncertainty
Despite all this, stocks were hovering near record highs going into Friday, as markets awaited the results from the parliamentary election in the U.K. -- which had this European ETF in focus. In a surprising twist, the U.K. election resulted in a hung parliament, but even this failed to deter investors. In fact, the Dow Jones Industrial Average (DJIA), Nasdaq Composite (COMP), and S&P 500 Index (SPX) all hit record highs on Friday thanks to a financial sector rally, while the CBOE Volatility Index (VIX) dropped to a 23-year low.
Nvidia Stock Explodes; Apple Stock Sells Off
As for individual equities,
Nvidia stock stole the show once again, after Citigroup said
NVDA shares could double. Not to be left behind, fellow semiconductor stocks Micron and AMD also got a boost, prompting bullish activity from
options traders -- though
Ambarella stock dropped after earnings. Alibaba stock also had a big week, thanks to a staggering
revenue forecast, while shares of
Tesla and Netflix hit record highs of their own. However, the Nasdaq -- along with the Dow and SPX -- took a sharp turn lower at the end of the week, dashing its hopes for a weekly win, highlighted by a huge drop for
Apple stock.
Drug Stocks Hot After ASCO Event
Drug stocks were also making headlines throughout the week following an American Society of Clinical Oncology (ASCO) event, and two big winners were
bluebird bio and
Loxo Oncology. Elsewhere in the sector, upbeat data on a
Parkinson's drug had this biotech jumping on the charts, while
NewLink Genetics dropped one-third of its value in one session. The Food and Drug Administration (FDA) had a big impact, too, sending
Calithera stock flying and crushing
Endo International.
Valeant made headlines as well, amid reports it could put its eye-surgery business up for sale.
Macy's Stock Sell-Off Puts Pressure on Retailers
Meanwhile, the retail sector remained under pressure, mostly due to big losses from
Macy's stock, though talks of
Nordstrom going private helped alleviate some of the pain. As expected, retailer
Tailored Brands made a huge move after
earnings, while analysts are remaining upbeat on this
sector peer despite its struggles on the charts. If history is any indicator,
retail stocks could struggle next week, too. Meanwhile, bearish analyst attention put a dent in
beverage stocks.
Stocks to Buy During Fed Week
While it's been an
unusually positive start to the year for the SPX, there seems to be plenty of buying opportunities to be found. For starters, we identified 25
stocks to buy during Fed weeks, while these two
penny stocks could also be attractive targets. But if you want to be a little more cautious ahead of the upcoming
Federal Reserve meeting, this
gold stock could break out.